- Home >
- Life Sciences >
- Biotechnology >
Biotechnology Industry Analysis and Statistics (since 2008 - p3)
All premium reports for Biotechnology Industry Analysis and Statistics (since 2008 - p3)
61-90 of 286 Premium Reports from 27 Publishers
MedImmune, Inc. - Strategic Analysis Review
- $ 125
- June 2009
MedImmune, Inc. - Strategic Analysis ReviewSummaryMedImmune, LLC.( MedImmune), a biotechnology company focused on the development, manufacture and commercialization of medicines for the indications in Infectious Diseases, Oncology, Inflammatory Disease, cardiovascular, gastrointestinal disease and n ...
Industries : Biotechnology
Biosimilars Series: Forecast Analysis
- $ 11 400
- June 2009
IntroductionThe high cost and utilization of biologic drugs, coupled to the growing need to curb pharmaceutical expenditure, provides considerable momentum to the emerging biosimilars market. With a biosimilar approval pathway in place in Europe and Japan, and imminently in the US, Datamonitor expec ...
Industries : Biotechnology
Synthetic Biology: Emerging Global Markets
- $ 4 850
- June 2009
- 241 pages
This Report:The global market for synthetic biology generated $233.8 million in 2008. This is expected to increase to $2.4 billion in 2013, for a compound annual growth rate (CAGR) of 59.8%.The chemicals and energy segment has the largest share of the market, worth $80.6 million in 2008. This should ...
Industries : Biotechnology
Pharmacogenomics for Clinical Use and in Drug Development
- $ 3 400
- June 2009
Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth. Applying pharmacogenomics would allow doctors to treat specific segments of the population based on their particular responses to ...
Industries : Biotechnology
Therapeutic Monoclonal Antibodies Markets
- $ 1 999
- June 2009
- 112 pages
Antibodies are proteins in the immune system that help the body defend against foreign invasion, particularly from pathogens and toxins. As such, a human-engineered therapeutic monoclonal antibody (mAb) is protein derived from the immune system through recombinant DNA technology that has the ability ...
Industries : Biotechnology
Clinical Bundle
- $ 10 369
- June 2009
The Clinical Bundle includes the following reports off the individual reports being purchased separately:? Clinical Chemistry Analyzers.? Clinical Immunoanalyzer Markets.? Clinical Laboratory Testing Volume 1: Reagents and Instruments.? Clinical Laboratory Testing Volume 2: Business Strategies.Clini ...
Industries : Biotechnology, Healthcare
Amgen, Inc.: Company Profile
- $ 350
- June 2009
This company profile offers a comprehensive analysis of the organization, its business segments, and competitors. It analyzes the business and marketing strategies adopted by the company, to gain a competitive edge in the industry. The profile also evaluates the strengths of the company and the oppo ...
Industries : Biotechnology
Baxter International Inc.: Company Profile
- $ 350
- June 2009
This company profile offers a comprehensive analysis of the organization, its business segments, and competitors. It analyzes the business and marketing strategies adopted by the company, to gain a competitive edge in the industry. The profile also evaluates the strengths of the company and the oppo ...
Industries : Biotechnology, Medical Devices
US Biotechnology Sector: Industry Profile
- $ 600
- June 2009
This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry ...
Industries : Biotechnology
UK Biotechnology Sector: Industry Profile
- $ 600
- June 2009
This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry ...
Industries : Biotechnology
Indian Biotechnology Sector: Industry Profile
- $ 600
- June 2009
This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry ...
Industries : Biotechnology
German Biotechnology Sector: Industry Profile
- $ 600
- June 2009
This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry ...
Industries : Biotechnology
France Biotechnology Sector: Industry Profile
- $ 600
- June 2009
This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry ...
Industries : Biotechnology
Canadian Biotechnology Sector: Industry Profile
- $ 600
- June 2009
This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry ...
Industries : Biotechnology
Chinese Biotechnology Sector: Industry Profile
- $ 600
- June 2009
This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry ...
Industries : Biotechnology
Japanese Biotechnology Sector: Industry Profile
- $ 600
- June 2009
This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry ...
Industries : Biotechnology
Australian Biotechnology Sector: Industry Profile
- $ 600
- June 2009
This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry ...
Industries : Biotechnology
Competitor Analysis: Aurora Kinase Inhibitors
- $ 219
- June 2009
Product description The present Competitive Intelligence Report about Aurora Kinase Inhibitors provides a competitor evaluation in the field of synthetic molecules targeting aurora kinase for treatment of cancer as of June 2009. Mitosis, a central event in tumor growth, is highly regulated to e ...
Industries : Biotechnology, Pharmaceutical
Competitor Analysis: MEK Inhibitors
- $ 188
- June 2009
Product description The present Competitive Intelligence Report about MEK Inhibitors provides a competitor evaluation in the field of synthetic molecules targeting MEK pathway for treatment of cancer as of June 2009. The mitogen activated protein kinases (MAPKs) are conserved proteins tha ...
Industries : Biotechnology, Pharmaceutical
Competitor Analysis: Raf Inhibitors
- $ 250
- May 2009
Product description The present Competitive Intelligence Report about Raf inhibitors provides a competitor evaluation in the field of synthetic molecules targeting Raf and mutant Raf (V600E) for treatment of cancer as of May 2009. The mitogen activated protein kinases (MAPKs) are conserved pro ...
Industries : Biopharmaceutical
US Stem Cell Market Analysis
- $ 800
- May 2009
Stem cell therapy ? the emerging therapy area that is drawing the attention of the pharmaceutical players worldwide ? refers to the therapy wherein a damaged tissue that cannot heal itself is repaired by the use of stem cell. The market for stem cells is constantly evolving, with researches going o ...
Industries : Biotechnology
Genentech, Inc. - SWOT Analysis
- $ 125
- May 2009
Datamonitor's Genentech, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Genentech, Inc. - SWOT Analysis examines the company?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines ...
Industries : Biotechnology, Healthcare
Stem Cell Research and Tissue Engineering: A Boon for Dental Tissue Regeneration
- $ 500
- May 2009
Stem Cell Research and Tissue Engineering: A Boon for Dental Tissue RegenerationSummaryGlobalData viewpoints are an essential source of high quality information on all key events in the medical equipment industry. GlobalData viewpoints are typically our opinion on the key events, strategic rationale ...
Industries : Biotechnology
Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition
- $ 3 995
- May 2009
Cell culture is a major foundation of biopharmaceutical development, bioprocessing and manufacturing. As the biopharmaceutical market grows, so should interest in the cell culture products market. Biopharmaceutical products are developed from large, complex protein molecules, which require equally c ...
Industries : Biotechnology
Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
- $ 3 995
- May 2009
The global market for human vaccines has experienced strong growth through 2008 and this is expected to continue through the forecast period. Growth will be fueled by new product introductions and rising usage in all regions. This report, Vaccines 2009: Key Players, and Critical Trends in a Fast-Cha ...
Industries : Biotechnology
China Listed Bio-pharmaceutical Companies Report, 2008
- $ 1 600
- May 2009
This report firstly gives an overview of China bio-pharmaceutical industry, and then analyses sub-industries, import & exports status of the industry; finally it expounds the operations and revenue, project investment, main business structure, latest development and future trend of key 20 bio-pharma ...
Industries : Biotechnology, Pharmaceutical
Competitor Analysis: NGF Agonists & Antagonists
- $ 125
- May 2009
Product description The present Competitive Intelligence Report about Nerve Growth Factor (NGF) Agonists & Antagonists provides a competitor evaluation in the field of investigational antibodies, small molecules and gene therapeutic approaches for treatment of chronic pain or Alzheimer&rsq ...
Industries : Biopharmaceutical
VIRxSYS Corporation - Strategic Analysis Review
- $ 3 500
- April 2009
VIRxSYS Corporation - Strategic Analysis ReviewSummaryThe VIRxSYS Corporation (VIRxSYS) is a privately held biotechnology company principally engaged in the development of gene based therapies using its proprietary lentiviral vector-based delivery system. The technology developed by the company is u ...
Industries : Biotechnology
Interleukin Genetics Incorporated - Financial and Strategic Analysis Review
- $ 125
- April 2009
Interleukin Genetics Incorporated - Financial and Strategic Analysis ReviewSummaryInterleukin Genetics Incorporated (Interleukin) is a genetics-focused personalized health company engages in the research, development, manufacture and sale of DNA based risk assessment tests. It is the biotechnology c ...
Industries : Biotechnology
Pharming Group N.V. - Financial and Strategic Analysis Review
- $ 125
- April 2009
Pharming Group N.V. - Financial and Strategic Analysis ReviewSummaryPharming Group N.V. (Pharming) is engaged in the development, manufacture and sale of nutritional products, surgical indications and applications towards the treatment and cure of genetic disorders and ageing diseases. The company?s ...
Industries : Biotechnology
reportlinker.com © Copyright 2009. All rights reserved